申请人:Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
公开号:US10647690B2
公开(公告)日:2020-05-12
The present invention relates to a 2,3-epoxy succinyl derivative, a preparation method and a use thereof, in particular, the present invention relates to a compound represented by Formula (1), a racemate or an optical isomer thereof, a solvate thereof, or a pharmaceutically acceptable salt thereof. The compound according to the present invention has good inhibitory activity and/or selectivity against cathepsin, especially Cathepsin B, can be used in the treatment of multiple diseases associated with cathepsin, for example, osteoporosis, rheumatoid arthritis and osteoarthritis that are associated with Cathepsin K, Ebola virus infection, a degenerative disease and an autoimmune disease that are associated with Cathepsin L, S, especially Cathepsin B-related tumor diseases, such as gastric cancer, cervical cancer, lung cancer, breast cancer, prostate cancer, bladder cancer, colon cancer, neuroglioma, and melanoma.
本发明涉及一种2,3-环氧琥珀酰衍
生物、其制备方法及其用途,特别是本发明涉及一种由式(1)表示的化合物、其外消旋体或光学异构体、其溶液或其药学上可接受的盐。根据本发明的化合物对
酪蛋白酶,特别是
酪蛋白酶 B 具有良好的抑制活性和/或选择性,可用于治疗与
酪蛋白酶相关的多种疾病,例如与
酪蛋白酶 K 相关的骨质疏松症、类风湿性关节炎和骨关节炎、埃博拉病毒感染、与
酪蛋白酶 L、S 相关的退行性疾病和自身免疫性疾病,特别是与
酪蛋白酶 B 相关的肿瘤疾病,如胃癌、宫颈癌、肺癌、乳腺癌、前列腺癌、膀胱癌、结肠癌、神经胶质瘤和
黑色素瘤。